pentobarbital will reduce the level or result of armodafinil here by influencing hepatic/intestinal enzyme CYP3A4 metabolism. minimal/importance Unknown.
pentobarbital will decrease the extent or impact of lorlatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the level or influence of disopyramide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. minimal/importance mysterious.
pentobarbital will reduce the level or influence of atazanavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. slight/importance not known.
Therapy ought to be administered with caution, if at all, to individuals who will be mentally depressed, have suicidal tendencies, or history of drug abuse
pentobarbital will lower the extent or effect of fostemsavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will reduce the level or influence of abiraterone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/observe.
pentobarbital will lessen the extent or result of zonisamide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. minimal/Significance unfamiliar.
pentobarbital will reduce the level or influence of ixabepilone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use warning/keep an eye on.
pentobarbital will reduce the extent or impact of vincristine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. minimal/importance unfamiliar.
clients stabilized on corticosteroid therapy may perhaps involve dosage adjustments if barbiturates are included to or withdrawn from their dosage program as a consequence of induction of hepatic microsomal enzymes by barbiturates
pentobarbital will lessen the level or effect of quinidine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/check.
pentobarbital will lower the level or effect of eplerenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. small/importance not known.
pentobarbital will reduce the extent or impact of brexpiprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/check carefully. Double brexpiprazole dose around one-two weeks if administered with a solid CYP3A4 inducer.